• Accueil >
  • Publications >
  • Molecular apocrine tumours in EORTC 10994/BIG 1-00 phase III study: pathological response after neoadjuvant chemotherapy and clinical outcomes

Molecular apocrine tumours in EORTC 10994/BIG 1-00 phase III study: pathological response after neoadjuvant chemotherapy and clinical outcomes

1 avr. 2019British Journal of Cancer

DOI : 10.1038/s41416-019-0420-y

Auteurs

Hervé Bonnefoi, , Gaetan MacGrogan, Coralie Poncet, Richard Iggo, Fanny Pommeret, Thomas Grellety, Denis Larsimont, Véronique Bécette, Olivier Kerdraon, Frédéric Bibeau, Jean-Pierre Ghnassia, Jean-Michel Picquenot, Jeremy Thomas, Jean-Christophe Tille, Leen Slaets, Alexandre Bodmer, Jonas Bergh, David Cameron